Moreover, EPO injection did not affect body weight, heart rate, blood pressure as well as serum lipid profiles of mice relative to the vehicle group (Figure S3, Supporting Information), which was in agreement with our previous results.[17] As formoterol was suggested by CMap database that might alleviate the EPO effect on aortas, we examined the dose‐response relation between formoterol and EPO‐induced AAA. The gene discussed is EPO; the disease is triple-A syndrome.